Padova

Italy

776 total trials 339 recruiting

Filter these 776 trials by phase, condition, sponsor and more.

Open in Search →

THIS IS A CLINICAL STUDY WHICH EVALUATES TREATMENT WITH CHLORAMBUCIL AND RITUXIMAB FOLLOWED BY RITUXIMAB GIVEN UNDER THE SKIN IN PATIENTS W … Ended

2023-507291-52-00 4 2014-03-24 Extranodal Marginal Zone Lymphoma
A trial to learn if andexanet alfa is safe and works to limit bleeding in people who take factor 10a inhibitors and urgently need surgery Ended

2022-501353-37-00 5 Reversal of anticoagulation effect in patients on a FXa inhibitor (api
Brightline-4: A study to test how well brigimadlin is tolerated by people with a type of cancer called dedifferentiated liposarcoma Ended

2023-504522-19-00 5 dedifferentiated liposarcoma
A dose-finding study to evaluate mRNA-3210 in participants with phenylketonuria Ended

2023-506963-32-00 7 Participants with Phenylketonuria
An Open-Label, Multicenter, Phase 1 Study Evaluating the Safety and Pharmacokinetics of ADU-1604 in Adults with Advanced Melanoma Ended

2024-511949-19-00 1 Metastatic Melanoma
A study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer (including fall … Ended

2024-512477-27-00 4 Advanced Epithelial Ovarian Cancer (including Fallopian Tube or Primar
AUSTRAL trial: An open-label, multicenter, phase II study of radiotherapy followed by durvalumab (MEDI4736) and ceralasertib (AZD6738) in st … Ended

2024-515942-18-01 4 Stage III NSCLC patients with loco-regional relapse > 12 months from t
A Phase II, open label, single arm, multicentre study on THOracic Radiotherapy in Extensive Stage SCLC patients submitted to first line CHT- … Ended

2024-517445-13-00 4 Extended stage small cell lung cancer patients confirmed histologicall

Showing 769–776 of 776 trials